These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35258401)

  • 1. Adult acute myeloid leukemia patients with
    Xie W; Raess PW; Dunlap J; Hoyos CM; Li H; Li P; Swords R; Olson SB; Yang F; Anekpuritanang T; Hu S; Wiszniewska J; Fan G; Press RD; Moore SR
    Leuk Lymphoma; 2022 Aug; 63(8):1907-1916. PubMed ID: 35258401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangement.
    Lauw MIS; Qi Z; Eversmeyer L; Prakash S; Wen KW; Yu J; Monaghan SA; Aggarwal N; Wang L
    Hum Pathol; 2022 May; 123():11-19. PubMed ID: 35167894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cryptic translocation leading to NUP98-PHF23 fusion in AML.
    Ning Y
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):320-323. PubMed ID: 27890253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Characteristics and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Gene Rearrangement].
    Lu N; Ding Y; Wu YL; Wang LL; Jing Y; Li HH; Li M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1450-1455. PubMed ID: 34627423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review.
    Fu W; Huang A; Cheng H; Luo Y; Gao L; Tang G; Yang J; Wang J; Ni X
    BMC Med Genomics; 2021 May; 14(1):130. PubMed ID: 34001105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.
    Mojarad BA; Crees ZD; Schroeder MC; Xiang Z; Vader J; Sina J; Jacoby M; Frater JL; Duncavage EJ; Spencer DH; Lavine K; Neidich JA; Amarillo I
    Cancer Genet; 2024 Jan; 280-281():1-5. PubMed ID: 38056049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular Characteristics and Clinical Features of Adults with
    Lun Y; Huang JC; Long D; Wang FF; Dai Y; Yang Y; Zhao TT; Li Q; Wu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):575-581. PubMed ID: 30378313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
    Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
    Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of NUP98/TOP1 and TOP1/NUP98 in de novo Acute Myeloid Leukemia with t(11;20)(p15;q12) and t(2;5)(q33;q31).
    Yamamoto K; Minami Y; Yakushijin K; Mizutani Y; Inui Y; Kawamoto S; Matsui K; Nakamachi Y; Kawano S; Matsuoka H; Minami H
    Cytogenet Genome Res; 2016; 150(3-4):287-292. PubMed ID: 28249294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single-institution experience.
    Konoplev S; Wang X; Tang G; Li S; Wang W; Xu J; Pierce SA; Jia F; Jorgensen JL; Ravandi F; Issa GC; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2022 Mar; 102(2):123-133. PubMed ID: 34964255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
    Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
    Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
    Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
    Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted gene sequencing and transcriptome sequencing reveal characteristics of NUP98 rearrangement in pediatric acute myeloid leukemia.
    Zhang JY; Chen CR; Qin JY; Shen DY; Liu LX; Song H; Xia T; Xu WQ; Wang Y; Zhu F; Fang MX; Shen HP; Liao C; Dong A; Cao SB; Tang YM; Xu XJ
    Eur J Med Res; 2024 Sep; 29(1):448. PubMed ID: 39223643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
    Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
    Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia.
    Kivioja JL; Lopez Martí JM; Kumar A; Kontro M; Edgren H; Parsons A; Lundán T; Wolf M; Porkka K; Heckman CA
    Leuk Lymphoma; 2018 Mar; 59(3):725-732. PubMed ID: 28776436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR.
    Akiki S; Dyer SA; Grimwade D; Ivey A; Abou-Zeid N; Borrow J; Jeffries S; Caddick J; Newell H; Begum S; Tawana K; Mason J; Velangi M; Griffiths M
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1053-64. PubMed ID: 23999921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
    Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.